Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement.
about
An increasing number of qualitative research papers in oncology and palliative care: does it mean a thorough development of the methodology of research?Patient experience in the treatment of metastatic castration-resistant prostate cancer: state of the scienceComputerized patient-reported symptom assessment in radiotherapy: a pilot randomized, controlled trial.Swallowing interventions for the treatment of dysphagia after head and neck cancer: a systematic review of behavioural strategies used to promote patient adherence to swallowing exercisesImpact of bowel dysfunction on quality of life after sphincter-preserving resection for rectal cancer.Distribution and determinants of patient satisfaction in oncology with a focus on health related quality of life.Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial.Evaluation of a complex intervention to improve activities of daily living of disabled cancer patients: protocol for a randomised controlled study and feasibility of recruitment and interventionQuality of life assessment as a predictor of survival in non-small cell lung cancerA longitudinal study investigating quality of life and nutritional outcomes in advanced cancer patients receiving home parenteral nutrition.Clinical relevance of quality-of-life data in laryngectomized patients.Phase ii/iii study of intraperitoneal chemotherapy after neoadjuvant chemotherapy for ovarian cancer: ncic ctg ov.21.Frequency of positive states of mind as a moderator of the effects of stress on psychological functioning and perceived health.Prognostic value of changes in quality of life scores in prostate cancer.Transoral robotic surgery for the treatment of T1-T2 carcinoma of the larynx: preliminary study.Fatigue in patients with advanced renal cell carcinoma receiving sunitinib on an intermittent versus continuous dosing schedule in a randomized phase II trial.Patient Activation through Counseling and Exercise--Acute Leukemia (PACE-AL)--a randomized controlled trial.Can changes in health related quality of life scores predict survival in stages III and IV colorectal cancer?The labour market, psychosocial outcomes and health conditions in cancer survivors: protocol for a nationwide longitudinal survey 2 and 5 years after cancer diagnosis (the VICAN survey).Randomised controlled trial of a shared care programme for newly referred cancer patients: bridging the gap between general practice and hospital.Palliative care in primary care: a study to determine whether patients and professionals agree on symptomsHealth-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors.Effectiveness of the "Cancer Home-Life Intervention" on everyday activities and quality of life in people with advanced cancer living at home: a randomised controlled trial and an economic evaluation.Enhanced involvement of general practitioners in cancer rehabilitation: a randomised controlled trial.Predicting survival in prostate cancer: the role of quality of life assessment.Quality of life and functional outcome after infravesical desobstruction and HIFU treatment for localized prostate cancerEffect of completion-time windows in the analysis of health-related quality of life outcomes in cancer patients.Quality of life in a prospective, multicenter phase 2 trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation in patients with resectable or borderline resectable pancreatic adenocarcinoma.Longitudinal health-related quality of life assessment: implications for prognosis in ovarian cancerLong-term follow-up after cancer rehabilitation using high-intensity resistance training: persistent improvement of physical performance and quality of life.Quality of life in a population of Polish patients with prostate cancer.Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancerSexual function after intracavitary vaginal brachytherapy for early-stage endometrial carcinoma.Physicians' Use of Patients' Daily Reports of Quality of Life to Evaluate Treatment Response in Phase I Cancer Trials.Temozolomide chemotherapy in patients with recurrent malignant gliomas.Validation of the simplified Chinese version of EORTC QLQ-C30 from the measurements of five types of inpatients with cancer.Impact of Pressurized Intraperitoneal Aerosol Chemotherapy on Quality of Life and Symptoms in Patients with Peritoneal Carcinomatosis: A Retrospective Cohort Study.Current status and future perspectives of patient-reported outcome research in clinical trials for patients with breast cancer in Japan.Focal low-dose rate brachytherapy for the treatment of prostate cancer.A parallel-group randomized clinical trial of individually tailored, multidisciplinary, palliative rehabilitation for patients with newly diagnosed advanced cancer: the Pal-Rehab study protocol.
P2860
Q24797677-5B4B1934-4DC8-4D77-995A-94E996016DB6Q26772883-81FF7FD2-D522-4F89-95FC-60AD1ED95A4FQ30718673-D7F39B00-977E-45E6-B5D7-1EBE52B595F1Q30834462-2F859204-0258-4262-93D7-5AF8B0B00A19Q33458897-8B69CA42-8BEE-41FD-AF29-E8DA8264E9B0Q33511664-EA7A2F17-5C0D-425C-B5A6-E5D81AA61CADQ33613709-80E61D18-D5C7-494A-8C36-01737F54B079Q33712377-AC583B67-FDA1-428A-9351-97D9AFE19C6FQ33993427-6AB51874-B457-44FE-BC8D-41FE84B223F3Q34076680-19E862E8-F8DB-4252-A9B5-AF44D3E78E27Q34213267-F6BECC3E-A442-499B-8DC7-93FDB3F6EA36Q34628651-F21131BA-4496-436C-9FCF-26DE62651F8CQ34729244-B82D7BFA-B6C8-48EF-99AA-FA0337FC2B08Q34803638-073FF0DA-DE5F-4D89-A6D3-90F55D1BE028Q34897689-5053BFB8-DCE2-448F-A0F7-C9EC3D19C7C7Q34998569-642A6E5B-5424-4E0E-897A-97D4E5C64D76Q35003602-FE8347F3-2F3F-46B0-9B04-9A1125383758Q35184088-16DB5FD1-4FBC-488C-8E2B-B95D2336C715Q35277965-2BE43562-640F-462C-95F6-E633AD1E2B58Q35526315-A4460D08-EE1C-4BF3-9F98-CEB266350401Q35678133-02452025-4F6B-4C2C-871B-6796B0194A7EQ35738251-5055D05F-CA2E-43A2-9382-C401F79B6044Q35902034-883B77E0-8CF5-44D7-8A06-1AC903BE29BBQ35904182-D1A13832-5689-4076-9948-AAC460D13E5CQ35928780-9C21318E-809C-4FAC-A022-63F60F4AB2A6Q36246724-0E1EA990-64A3-4CBE-9AC2-29AC6199CED1Q36474893-0CE34B80-B6FD-4688-B8DC-B6C793A51A5FQ36574645-C508C634-F40C-4AC2-9B39-5DAD1C6ED598Q36694571-7586BE7D-B43B-4C40-BE5C-673351BCFE8FQ36755169-C8F574ED-F04E-42D9-A0D2-1D11A5E5D321Q36840676-D1AC3D37-9B56-4915-89B9-291F0BD2889AQ36952096-2AE6794A-6FA7-4CF7-BECF-DD9FEC4ACEA8Q37139359-EE615A84-70A6-412B-A89D-78458C865166Q37184128-D429102C-D2C8-460D-8C0D-FF82303FC681Q37313220-DA093C31-DD50-4B9E-B194-B26C49C7406CQ37321901-4AC5A0BC-91E8-4E2A-8EF6-64413C9BAF6BQ37683464-9AFAB770-84D4-403B-AFCE-8580D07C5EA7Q38008568-8B2D8898-FF87-4BCE-B170-0B5F3069AFA6Q38139392-7CE2979D-927D-4D20-890B-6F7B3C5E07D1Q38371748-50D7B64F-4720-4A78-B388-23261EA0FD6B
P2860
Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Validation of the EORTC QLQ-C3 ...... of patient-observer agreement.
@en
Validation of the EORTC QLQ-C3 ...... of patient-observer agreement.
@nl
type
label
Validation of the EORTC QLQ-C3 ...... of patient-observer agreement.
@en
Validation of the EORTC QLQ-C3 ...... of patient-observer agreement.
@nl
prefLabel
Validation of the EORTC QLQ-C3 ...... of patient-observer agreement.
@en
Validation of the EORTC QLQ-C3 ...... of patient-observer agreement.
@nl
P2093
P1476
Validation of the EORTC QLQ-C3 ...... of patient-observer agreement.
@en
P2093
Aaronson NK
Groenvold M
Sprangers MA
P304
P356
10.1016/S0895-4356(96)00428-3
P577
1997-04-01T00:00:00Z